Nahrungsmittelunverträglichkeiten

Schlüsselwörter

Nahrungsmittelunverträglichkeit - Immuntherapie - peanut allergy - Kohlenhydrat-Malabsorption - FODMAP - Glutenunverträglichkeit

Keywords

food intolerance - immunotherapy - peanut allergy - carbohydrate malabsorption - FODMAP - gluten intolerance

• Literatur

• 1 Anagnostou K, Islam S, King Y et al. Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial. Lancet 2014; 383: 1297-1304
• 2 Baptist AP, Dever SI, Greenhawt MJ et al. A self-regulation intervention can improve quality of life for families with food allergy. J Allergy Clin Immunol 2012; 130: 263-265
• 3 Barrett JS, Gearry RB, Muir JG et al. Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon. Aliment Pharmacol Ther 2010; 31: 874-882
• 4 Biesiekierski JR, Newnham ED, Irving PM et al. Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial. Am J Gastroenterol 2011; 106: 508-514
• 5 Biesiekierski JR, Peters SL, Newnham ED et al. No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology 2013; 145: 320-328
• 6 Burks AW. Peanut allergy. Lancet 2008; 371: 1538-1546
• 7 Carroccio A, Mansueto P, Iacono G et al. Non-celiac wheat sensitivity diagnosed by double-blind placebo-controlled challenge: exploring a new clinical entity. Am J Gastroenterol 2012; 107: 1898-906
• 8 de Roest RH, Dobbs BR, Chapman BA et al. The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study. Int J Clin Pract 2013; 67: 895-903
• 9 Fleischer DM, Burks AW, Vickery BP et al. Consortium of Food Allergy Research (CoFAR). Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial. J Allergy Clin Immunol 2013; 131: 119-127
• 10 Fleischer DM, Perry TT, Atkins D et al. Allergic reactions to foods in preschool-aged children in a prospective observational food allergy study. Pediatrics 2012; 130 (01) e25-32 DOI: 10.1542/peds.2011-1762.
• 11 Halmos EP, Power VA, Shepherd SJ et al. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology 2014; 146: 67-75
• 12 Junker Y, Zeissig S, Kim SJ et al. Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4. J Exp Med 2012; 209: 2395-2408
• 13 Nijeboer P, Bontkes HJ, Mulder CJ et al. Non-celiac gluten sensitivity. Is it in the gluten or the grain?. J Gastrointestin Liver Dis 2013; 22: 435-440
• 14 Nwaru BI, Hickstein L, Panesar SS et al. the EAACI Food Allergy and Anaphylaxis Guidelines Group. Prevalence of common food allergies in Europe: a systematic review and meta-analysis. Allergy 2014; May 10. doi: DOI: 10.1111/all.12423. [Epub ahead of print]
• 15 Ong DK, Mitchell SB, Barrett JS et al. Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J Gastroenterol Hepatol 2010; 25: 1366-1373
• 16 Vickery BP, Scurlock AM, Kulis M et al. Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy. J Allergy Clin Immunol 2014; 133: 468-475
• 17 Wasserman RL, Factor JM, Baker JW et al. Oral immunotherapy for peanut allergy: multipractice experience with epinephrine-treated reactions. J Allergy Clin Immunol Pract 2014; 2: 91-96